Corcept Therapeutics | CORT - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Alaunos Therapeutics USD -1.01M 175K 2026-03
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Ardelyx USD -32.79M 37.89M 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Canopy Growth CAD -27.47M 14.81M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
J&J USD 7.48B 860M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.75B 515M 2026-06
Novartis USD 4.24B 171M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD 667M 4.32B 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06